Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001031462 | SCV001194768 | pathogenic | Ehlers-Danlos syndrome, type 4 | 2019-11-18 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the COL3A1 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of COL3A1 have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 20648054). Loss-of-function variants in COL3A1 are known to be pathogenic (PMID: 24922459). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV001386250 | SCV001586396 | pathogenic | Ehlers-Danlos syndrome, classic type | 2020-01-13 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the COL5A2 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of COL5A2 have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 20648054). Loss-of-function variants in COL5A2 are known to be pathogenic (PMID: 23587214). For these reasons, this variant has been classified as Pathogenic. |